The Antimicrobial Susceptibility Testing Market in 2024: Trends and Predictions

Posted by mayur pande on July 5th, 2024

Antimicrobial Susceptibility Testing Market Outlook, Scope & Overview:

Industry reports indicate that the global antimicrobial susceptibility testing market was valued at USD 3.57 billion in 2023 and is projected to reach USD 5.35 billion by 2031, growing at a CAGR of 5.2% over the forecast period 2024-2031.

Technological Advancements to Drive Growth of Global Antimicrobial Susceptibility Testing Market

The adoption of advanced antimicrobial susceptibility testing techniques will continue to influence global market revenues. Healthcare professionals are increasingly relying on these tests due to their critical role in identifying the most effective antibiotics for treating infections.

As a product type segment, automated AST instruments currently hold a significant share of the global antimicrobial susceptibility testing market. This segment is anticipated to grow at a year-over-year rate of 5.2% in 2024 over 2023 and reach USD 4 billion in revenues. A substantial increase in the adoption of automated AST systems is expected, driven by factors such as advancements in testing methods and the rising prevalence of antibiotic-resistant infections.

Automated Antimicrobial Susceptibility Testing Systems – Market Dynamics

Drivers:

Automated antimicrobial susceptibility testing systems are witnessing significant growth in the global market due to their efficiency and accuracy in determining the susceptibility of pathogens to antibiotics. The use of these advanced systems has increased in various healthcare settings, including hospitals, laboratories, and research centers. Moreover, the rising incidence of drug-resistant infections and the need for precise and rapid testing solutions are driving the demand for automated AST systems. Additionally, the integration of these systems in routine diagnostic workflows and the development of high-throughput testing methods are expected to further fuel market growth.

Restraints:

Despite the growth potential, challenges such as high costs associated with automated AST systems and the need for specialized personnel to operate these systems are hindering their widespread adoption. Additionally, the regulatory complexities and the time required for approval of new testing methods can also impact the growth of the automated antimicrobial susceptibility testing market.

Automated Antimicrobial Susceptibility Testing Systems – Market Outlook

The effective diagnostic outcomes observed from the use of automated AST systems in identifying effective antibiotics have boosted the prominence of this technology in the global market. Automated AST systems are projected to witness steady growth in demand, particularly in developed regions where healthcare infrastructure is advanced.

Global Antimicrobial Susceptibility Testing Market

The rise in demand for automated AST systems in North America, Europe, and Asia Pacific regions is expected to drive market growth over the forecast period. North America currently holds a significant market share in the global antimicrobial susceptibility testing market, with the US being a key contributor to market revenues. Europe and Asia Pacific regions are also experiencing a surge in demand for automated AST systems, fueled by increasing prevalence of antibiotic-resistant infections and advancements in testing technologies.

Key Players in the Automated Antimicrobial Susceptibility Testing Market

Leading companies in the automated antimicrobial susceptibility testing market include bioMérieux, Thermo Fisher Scientific, BD (Becton, Dickinson and Company), and Danaher Corporation. These companies offer a range of automated AST solutions, including high-throughput testing systems, rapid diagnostic platforms, and integrated workflow solutions.

In conclusion, the global antimicrobial susceptibility testing market is poised for steady growth over the forecast period, driven by technological advancements, increasing prevalence of drug-resistant infections, and the growing need for accurate and efficient testing solutions.